Weill Cornell Medicine Clinical & Translational Science Center


Mission Statement

The Weill Cornell Clinical and Translational Science Center is a partnership of renowned institutions mostly located
on the East Side of New York City that has focused on catalyzing translational research to improve human health over the past
14 years. Under the leadership of Julianne Imperato-McGinley, MD researchers are collaborating, education programs are
united and resources and technological tools are efficiently shared and utilized in novel ways to accelerate multi-disciplinary
trans-institutional team science. The overall vision of the Weill Cornell CTSC is to build upon our effective CTSC
platform to further extend clinical and translational research across the spectrum of translational science with community
involvement at all phases. We plan to advance creativity and entrepreneurship, critical elements to foster the translation and
dissemination of novel discoveries and initiatives. Our CTSC partners each have unique features that bring diversity to multi-institutional
multi-disciplinary team research leading to novel technology development. Multimodal opportunities for learning
are planned to add flexibility in the education of translational researchers, allied professionals, and community members. Our
mission will be further augmented by expanding our informatics structure and technology while we continue to enhance our
activity as members of the CTSA national consortium concerning nationwide initiatives and best practices, in addition to
disseminating findings and collaborating across hubs nationally.

At a Glance


Educational Resources Posted


Consortium News Stories Posted


Events Posted


Opportunities Posted


Publications citing CTSA Program Grant


Users from Hub Registered

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2020
Connect with Us
Page Administrators
Grenald, MPA
Executive Director

Consortium News

The Weill Cornell Clinical and Translational Science Center (CTSC) with partner Hunter College School of Nursing, initiated a community vaccination program in February 2020 for underserved communities in New York City. Alarmed by the growing disparities in vaccination of minorities, Reverend Patrick O’Connor of First Presbyterian Church in Jamaica Queens, reached out to Julianne Imperato-McGinley

Weill Medical College of Cornell University

What is it? The Bronfenbrenner Center for Translational Research is offering its 2nd annual Cornell Translational Research Summer Institute (CTRSI). Over several decades, the Bronfenbrenner Center has developed extensive expertise in conducting research in real-world settings and translating empirical findings into practice. Over the course of 2.5 days, the 2019 CTRSI will provide intensive


Serves as the primary interface to the national CTSA Trial Innovation Network (TIN), comprised of three organizational partners: the CTSA Program Hubs, the Trial Innovation Centers (TIC) and Recruitment Innovation Center (RIC). This role also serves as a primary point of contact for new and existing researchers during the initiation and ongoing conduct of multicenter clinical trials and oversees

Poster Sessions

Weill Medical College of Cornell University

Hospital readmissions are frequent, costly, and potentially harmful, and some are considered preventable. Factors that affect readmissions after hospitalization for COVID-19 and their preventability are unknown. We examined hospital readmissions among COVID-19 patients in two New York City hospitals to describe the characteristics of patients who had COVID-19 hospital readmissions at these two


Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation

During the germinal center (GC) reaction, B cells undergo extensive redistribution of cohesin complex and three-dimensional reorganization of their genomes. Yet, the significance of cohesin and architectural programming in the humoral immune response is unknown. Herein we report that homozygous

Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale

Although the concept of pathological grief dates back at least as far as Freud's "Mourning and Melancholia", there has been opposition to its recognition as a distinct mental disorder. Resistance has been overcome by evidence demonstrating that distinctive symptoms of prolonged grief disorder (PGD)

Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses

Adoptive cell therapy using cytomegalovirus (CMV)-specific cytotoxic T lymphocytes (CMV-CTLs) has demonstrated efficacy posttransplant. Despite the predicted limited engraftment of CMV-CTLs derived from third-party donors, partially matched third-party donor-derived CMV-CTLs have demonstrated